|
|
Volumn 40, Issue 7, 2001, Pages 464-467
|
|
A clinical study to determine the efficacy and safety of 1% methotrexate/Azone® (MAZ) gel applied topically once daily in patients with psoriasis vulgaris
a,b,c,d
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LAUROCAPRAM;
METHOTREXATE;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CLINICAL FEATURE;
CLINICAL LABORATORY;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DESQUAMATION;
DISEASE SEVERITY;
DOSE TIME EFFECT RELATION;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG DOSAGE FORM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FEMALE;
GEL;
HEADACHE;
HEMATOLOGICAL PARAMETERS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PSORIASIS VULGARIS;
SYMPTOM;
THICKNESS;
TOXICITY;
ADMINISTRATION, CUTANEOUS;
ADULT;
AGED;
DERMATOLOGIC AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
GELS;
HEADACHE;
HUMANS;
MALE;
METHOTREXATE;
MIDDLE AGED;
PRURITUS;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
SKIN;
TREATMENT OUTCOME;
|
|
EID: 0034757021
PISSN: 00119059
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-4362.2001.01244.x Document Type: Article |
|
Times cited : (35)
|
|
References (4)
|
